Abstract

Background

Magnetic sphincter augmentation (MSA) has emerged as an alternative surgical treatment of gastroesophageal reflux disease (GERD). The safety and efficacy of MSA has been previously demonstrated, although adequate comparison to Nissen fundoplication (NF) is lacking, and required to validate the role of MSA in GERD management.

Methods

A multi-institutional retrospective cohort study of patients with GERD undergoing either MSA or NF. Comparisons were made at 1 year for the overall group and for a propensity-matched group.

Conclusions

MSA for uncomplicated GERD achieves similar improvements in quality of life and symptomatic relief, with fewer side effects, but lower PPI elimination rates when compared to propensity-matched NF cases. In appropriate candidates, MSA is a valid alternative surgical treatment for GERD management.

Notes

Acknowledgments

Dr. Heather Warren’s Advanced Gastrointestinal Surgery Fellowship at Swedish Medical Center was supported in part by the Ryan Hill Foundation.

Compliance with ethical standards

Disclosures

Drs. Lipham, Taiganides and Louie have received consulting fees from Torax Medical. Drs. Warren, Reynolds, Zehetner, Bildzukewicz, Aye, and Farivar, and Ms. Mickley have no conflicts of interest or financial ties to disclose.